Investors | Novartis

We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

R&D Investor Event 2023

November 28, 2023 | London, UK

Read the media release

Watch the webcast
14:30 CET | 13:30 GMT | 08:30 EST

Access our interactive presentation (PDF 15 MB)

Walkway at the entrance of the Novartis Campus in Basel, Switzerland

Investors Event Calendar

View recent presentations and learn more about upcoming events.

Learn more

Third quarter results 2023

October 24, 2023 | Basel, Switzerland

Media release:
English (PDF 0.4 MB) | Deutsch (PDF 0.4 MB) | Français (PDF 0.5 MB)

Interim financial report (PDF 0.6 MB)

Watch the webcast

Download the podcast (MP3 33 MB)

Download the interactive presentation (PDF 3.5 MB)

Novartis Q3 2023 Impact and Sustainability Update (PDF 1.0 MB)

Learn more

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

Learn more

ESG Updates: November 2023 (PDF 1.0 MB) | August 2023 (PDF 0.3 MB) | May 2023 (PDF 1.9 MB) | February 2023 (PDF 0.9 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Explore the ESG indices

Stocks